S. No. | Title and Authors Name |
---|---|
1 |
Expert opinion on fixed-dose combinations of Sitagliptin + metformin and the triple drug combination of Voglibose + Glimepiride + Metformin in the management of type 2 diabetes mellitus in Indian settings
Dr. Manjula S and Krishna Kumar M
Int. J. Endocrinol. Sci., 2024; 6(1): 01-06
|
2 |
Quantifying Protein loss in patients living with diabetes mellitus (PLWD) in resource-limited settings: Urine ACR or PCR?
Prasun Singh, Somasundram Pillay, Tyrone Nicholas Rajah and Rushern Ruvashin Chetty
Int. J. Endocrinol. Sci., 2024; 6(1): 07-11
|
3 |
Supplementing liothyronine to levothyroxine therapy for management of hypothyroidism: Current clinical practice and beyond
Abhyudaya Verma
Int. J. Endocrinol. Sci., 2024; 6(1): 12-16
|
4 |
Genetic mutations and their impact on pituitary gland function
Aziz Talbi and Mohamed Elalami
Int. J. Endocrinol. Sci., 2024; 6(1): 17-19
|
5 |
Expert opinion on the use of SGLT2 inhibitors and its combination with a special focus on dapagliflozin in the management of type 2 diabetes in Indian settings
Manjula S and Krishna Kumar M
Int. J. Endocrinol. Sci., 2024; 6(1): 20-26
|